# Neurotropin Treatment of Fibromyalgia

> **NCT00366535** · PHASE2 · COMPLETED · sponsor: **National Institute of Nursing Research (NINR)** · enrollment: 56 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Placebo
- **DRUG:** Neurotropin

## Key facts

- **NCT ID:** NCT00366535
- **Lead sponsor:** National Institute of Nursing Research (NINR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-06-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00366535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00366535, "Neurotropin Treatment of Fibromyalgia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00366535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*